

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | activated T cell proliferation (GO:0050798) | 5.65442493 |
| 2 | tolerance induction (GO:0002507) | 5.11741757 |
| 3 | negative T cell selection (GO:0043383) | 5.07640503 |
| 4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.80072830 |
| 5 | negative thymic T cell selection (GO:0045060) | 4.74107306 |
| 6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.62889803 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.49739286 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.49739286 |
| 9 | cellular response to interleukin-15 (GO:0071350) | 4.28150272 |
| 10 | thymic T cell selection (GO:0045061) | 4.20715282 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.11428165 |
| 12 | positive T cell selection (GO:0043368) | 4.09941164 |
| 13 | response to interleukin-15 (GO:0070672) | 4.01881597 |
| 14 | behavioral response to nicotine (GO:0035095) | 3.94234049 |
| 15 | T cell selection (GO:0045058) | 3.87565052 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.87461443 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.62047915 |
| 18 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.58311253 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.50408558 |
| 20 | leukocyte aggregation (GO:0070486) | 3.50327970 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.44926728 |
| 22 | positive thymic T cell selection (GO:0045059) | 3.42641838 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42536574 |
| 24 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42076351 |
| 25 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.40906866 |
| 26 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.40906866 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33292365 |
| 28 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.28284511 |
| 29 | interferon-gamma production (GO:0032609) | 3.25185957 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23924821 |
| 31 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.23032574 |
| 32 | DNA deamination (GO:0045006) | 3.16239894 |
| 33 | regulation of regulatory T cell differentiation (GO:0045589) | 3.12173284 |
| 34 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.11673396 |
| 35 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.10918471 |
| 36 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.08416705 |
| 37 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.08267812 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.05192175 |
| 39 | piRNA metabolic process (GO:0034587) | 3.01360067 |
| 40 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.99813477 |
| 41 | alpha-beta T cell differentiation (GO:0046632) | 2.99558526 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.99455858 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98312048 |
| 44 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98127965 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 2.94575724 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93624497 |
| 47 | positive regulation of cell killing (GO:0031343) | 2.92485663 |
| 48 | transmission of nerve impulse (GO:0019226) | 2.92387876 |
| 49 | regulation of cell killing (GO:0031341) | 2.83390794 |
| 50 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.82704549 |
| 51 | DNA methylation involved in gamete generation (GO:0043046) | 2.82602189 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 2.80373753 |
| 53 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.74094647 |
| 54 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.73240057 |
| 55 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73232078 |
| 56 | L-fucose catabolic process (GO:0042355) | 2.73225178 |
| 57 | fucose catabolic process (GO:0019317) | 2.73225178 |
| 58 | L-fucose metabolic process (GO:0042354) | 2.73225178 |
| 59 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.70727028 |
| 60 | positive regulation of interleukin-4 production (GO:0032753) | 2.69970706 |
| 61 | T cell receptor signaling pathway (GO:0050852) | 2.68036538 |
| 62 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65057460 |
| 63 | mast cell degranulation (GO:0043303) | 2.62544660 |
| 64 | mast cell activation involved in immune response (GO:0002279) | 2.62544660 |
| 65 | regulation of T cell differentiation in thymus (GO:0033081) | 2.62074820 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62050733 |
| 67 | T cell homeostasis (GO:0043029) | 2.61382479 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.59183167 |
| 69 | primary amino compound metabolic process (GO:1901160) | 2.58119563 |
| 70 | negative regulation of B cell mediated immunity (GO:0002713) | 2.56992142 |
| 71 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.56992142 |
| 72 | regulation of interleukin-4 production (GO:0032673) | 2.56912196 |
| 73 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.56142590 |
| 74 | T-helper cell differentiation (GO:0042093) | 2.56142590 |
| 75 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.54935213 |
| 76 | Peyers patch development (GO:0048541) | 2.54935213 |
| 77 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.53887457 |
| 78 | T cell differentiation involved in immune response (GO:0002292) | 2.51456151 |
| 79 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.51456151 |
| 80 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.51456151 |
| 81 | mast cell activation (GO:0045576) | 2.50151025 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.49937300 |
| 83 | regulation of T cell tolerance induction (GO:0002664) | 2.49468401 |
| 84 | alpha-beta T cell activation (GO:0046631) | 2.48908532 |
| 85 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.44093379 |
| 86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.44051822 |
| 87 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.42702852 |
| 88 | negative regulation of adaptive immune response (GO:0002820) | 2.41574937 |
| 89 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.38518130 |
| 90 | T cell differentiation (GO:0030217) | 2.37268336 |
| 91 | regulation of chronic inflammatory response (GO:0002676) | 2.36784159 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.35631733 |
| 93 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.35606666 |
| 94 | positive regulation of defense response to virus by host (GO:0002230) | 2.34834295 |
| 95 | positive regulation of Rap GTPase activity (GO:0032854) | 2.34831992 |
| 96 | neurotransmitter secretion (GO:0007269) | 2.34741513 |
| 97 | T cell mediated immunity (GO:0002456) | 2.29525152 |
| 98 | T cell migration (GO:0072678) | 2.28709493 |
| 99 | positive regulation of protein homooligomerization (GO:0032464) | 2.28207636 |
| 100 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.27868890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.44386328 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.40281993 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.57829024 |
| 4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50256355 |
| 5 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.49373248 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.45589275 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28625505 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.19785463 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09846644 |
| 10 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01540341 |
| 11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93850026 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.93547475 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.87719042 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75872062 |
| 15 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74489214 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.73302765 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72437938 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63311412 |
| 19 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.61970557 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58029472 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47961442 |
| 22 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.47932411 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 1.47765774 |
| 24 | P68_20966046_ChIP-Seq_HELA_Human | 1.46528118 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45586489 |
| 26 | ERA_21632823_ChIP-Seq_H3396_Human | 1.45277623 |
| 27 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41719681 |
| 28 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.39211442 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37978418 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37247166 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37207048 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36394068 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.35372290 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35272352 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.34838302 |
| 36 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34677716 |
| 37 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.32038066 |
| 38 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29951704 |
| 39 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29886327 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.27062408 |
| 41 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.25859232 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25033339 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24160676 |
| 44 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23451404 |
| 45 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.23161735 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.22406601 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20929400 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20310826 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.19289165 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18244046 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17918244 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.16583353 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15924492 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15237167 |
| 55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15183451 |
| 56 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13364440 |
| 57 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12999668 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12877014 |
| 59 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.10523448 |
| 60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10427334 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09459490 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09187873 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07509448 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06655219 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.06483170 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05814191 |
| 67 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05525267 |
| 68 | P300_27268052_Chip-Seq_Bcells_Human | 1.05058156 |
| 69 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03190111 |
| 70 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.02975660 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00695701 |
| 72 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00430723 |
| 73 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00386492 |
| 74 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99396928 |
| 75 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98553016 |
| 76 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97395394 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97395394 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97249220 |
| 79 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.96948575 |
| 80 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96827086 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96695372 |
| 82 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96636165 |
| 83 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95653251 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95558248 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95419083 |
| 86 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.94192457 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93700544 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93700544 |
| 89 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92313345 |
| 90 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91452642 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91012785 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90048307 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89100569 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89064637 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88926586 |
| 96 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.88645582 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87576163 |
| 98 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87573512 |
| 99 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87492311 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86567657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.37678133 |
| 2 | MP0001873_stomach_inflammation | 3.04018191 |
| 3 | MP0008877_abnormal_DNA_methylation | 2.89599349 |
| 4 | MP0005671_abnormal_response_to | 2.74715671 |
| 5 | MP0003787_abnormal_imprinting | 2.57658693 |
| 6 | MP0004381_abnormal_hair_follicle | 2.42751734 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 2.13599953 |
| 8 | MP0004043_abnormal_pH_regulation | 2.04508777 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.02378100 |
| 10 | MP0009745_abnormal_behavioral_response | 2.01906128 |
| 11 | MP0001800_abnormal_humoral_immune | 1.92290080 |
| 12 | MP0004742_abnormal_vestibular_system | 1.85645143 |
| 13 | MP0001986_abnormal_taste_sensitivity | 1.82611519 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 1.81940269 |
| 15 | MP0002822_catalepsy | 1.78302774 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 1.74382814 |
| 17 | MP0005310_abnormal_salivary_gland | 1.73292108 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 1.73109790 |
| 19 | MP0002064_seizures | 1.72359513 |
| 20 | MP0002653_abnormal_ependyma_morphology | 1.72020005 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 1.69765607 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.69394335 |
| 23 | MP0003866_abnormal_defecation | 1.68386294 |
| 24 | MP0002163_abnormal_gland_morphology | 1.68192565 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.67338813 |
| 26 | MP0002272_abnormal_nervous_system | 1.63529983 |
| 27 | MP0001348_abnormal_lacrimal_gland | 1.61465405 |
| 28 | MP0003880_abnormal_central_pattern | 1.59355895 |
| 29 | MP0003195_calcinosis | 1.58939910 |
| 30 | MP0001790_abnormal_immune_system | 1.58141854 |
| 31 | MP0005387_immune_system_phenotype | 1.58141854 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.56437255 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.53944204 |
| 34 | MP0008961_abnormal_basal_metabolism | 1.51805930 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.48626361 |
| 36 | MP0000685_abnormal_immune_system | 1.45442757 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.42633037 |
| 38 | MP0004142_abnormal_muscle_tone | 1.41357362 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.39376627 |
| 40 | MP0002928_abnormal_bile_duct | 1.39193263 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.36798172 |
| 42 | MP0008872_abnormal_physiological_respon | 1.32466392 |
| 43 | MP0001919_abnormal_reproductive_system | 1.32420053 |
| 44 | MP0002723_abnormal_immune_serum | 1.31744842 |
| 45 | MP0004885_abnormal_endolymph | 1.31125503 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.27999335 |
| 47 | MP0009046_muscle_twitch | 1.27906583 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.26784160 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.23854871 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.23201267 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.23101121 |
| 52 | MP0002693_abnormal_pancreas_physiology | 1.22706141 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.21546609 |
| 54 | MP0001486_abnormal_startle_reflex | 1.21169215 |
| 55 | MP0001970_abnormal_pain_threshold | 1.20006844 |
| 56 | MP0001819_abnormal_immune_cell | 1.18868982 |
| 57 | MP0001765_abnormal_ion_homeostasis | 1.17591859 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.16220412 |
| 59 | MP0002733_abnormal_thermal_nociception | 1.15201229 |
| 60 | MP0003123_paternal_imprinting | 1.14186347 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.13937449 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.13481843 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.10573277 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.09631816 |
| 65 | MP0003878_abnormal_ear_physiology | 1.09631816 |
| 66 | MP0000427_abnormal_hair_cycle | 1.09514723 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.08368858 |
| 68 | MP0003646_muscle_fatigue | 1.07699340 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.06909653 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.06371144 |
| 71 | MP0002398_abnormal_bone_marrow | 1.03523626 |
| 72 | MP0000716_abnormal_immune_system | 1.02843059 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.02672278 |
| 74 | MP0002254_reproductive_system_inflammat | 1.02285269 |
| 75 | MP0008569_lethality_at_weaning | 1.01928719 |
| 76 | MP0004130_abnormal_muscle_cell | 1.01357225 |
| 77 | MP0003879_abnormal_hair_cell | 1.01139095 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.00820079 |
| 79 | MP0004924_abnormal_behavior | 0.97671929 |
| 80 | MP0005386_behavior/neurological_phenoty | 0.97671929 |
| 81 | MP0001835_abnormal_antigen_presentation | 0.95272258 |
| 82 | MP0003436_decreased_susceptibility_to | 0.94121842 |
| 83 | MP0005389_reproductive_system_phenotype | 0.94117483 |
| 84 | MP0001905_abnormal_dopamine_level | 0.93232711 |
| 85 | MP0005025_abnormal_response_to | 0.92515672 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.92071268 |
| 87 | MP0004947_skin_inflammation | 0.88823081 |
| 88 | MP0002184_abnormal_innervation | 0.88077167 |
| 89 | MP0000689_abnormal_spleen_morphology | 0.87596779 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87159191 |
| 91 | MP0003136_yellow_coat_color | 0.86846184 |
| 92 | MP0005646_abnormal_pituitary_gland | 0.86119132 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.85080869 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.84478980 |
| 95 | MP0001188_hyperpigmentation | 0.82428446 |
| 96 | MP0002229_neurodegeneration | 0.81857593 |
| 97 | MP0002405_respiratory_system_inflammati | 0.80057356 |
| 98 | MP0005448_abnormal_energy_balance | 0.79844198 |
| 99 | MP0002736_abnormal_nociception_after | 0.77949296 |
| 100 | MP0002160_abnormal_reproductive_system | 0.77223800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive cerebellar ataxia (HP:0002073) | 3.79642611 |
| 2 | Stomatitis (HP:0010280) | 3.48384369 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47840062 |
| 4 | Congenital stationary night blindness (HP:0007642) | 3.30159549 |
| 5 | Increased circulating renin level (HP:0000848) | 3.22279880 |
| 6 | Metabolic alkalosis (HP:0200114) | 3.08973114 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.05985663 |
| 8 | Polydipsia (HP:0001959) | 3.00535950 |
| 9 | Abnormal drinking behavior (HP:0030082) | 3.00535950 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95718887 |
| 11 | T lymphocytopenia (HP:0005403) | 2.87687777 |
| 12 | Polyuria (HP:0000103) | 2.85864502 |
| 13 | Genetic anticipation (HP:0003743) | 2.81387126 |
| 14 | Papilledema (HP:0001085) | 2.80857523 |
| 15 | Hypokalemic alkalosis (HP:0001949) | 2.72402100 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 2.64791451 |
| 17 | Hypomagnesemia (HP:0002917) | 2.62523480 |
| 18 | Epileptic encephalopathy (HP:0200134) | 2.62517909 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 2.60781074 |
| 20 | Febrile seizures (HP:0002373) | 2.55281703 |
| 21 | Pancreatic cysts (HP:0001737) | 2.55033720 |
| 22 | Abnormality of chloride homeostasis (HP:0011422) | 2.53695036 |
| 23 | Abnormality of renin-angiotensin system (HP:0000847) | 2.51028224 |
| 24 | IgG deficiency (HP:0004315) | 2.49153051 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 2.48134194 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 2.48134194 |
| 27 | Tubular atrophy (HP:0000092) | 2.43752110 |
| 28 | Abnormality of T cells (HP:0002843) | 2.42403766 |
| 29 | Type II lissencephaly (HP:0007260) | 2.41300758 |
| 30 | Focal motor seizures (HP:0011153) | 2.35064030 |
| 31 | Pustule (HP:0200039) | 2.33804575 |
| 32 | Hyperventilation (HP:0002883) | 2.32869708 |
| 33 | Myokymia (HP:0002411) | 2.32277222 |
| 34 | Abnormal urine output (HP:0012590) | 2.27188340 |
| 35 | Abnormality of the renal cortex (HP:0011035) | 2.24339251 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.20863778 |
| 37 | Abnormality of renal excretion (HP:0011036) | 2.19848495 |
| 38 | Abnormality of eosinophils (HP:0001879) | 2.19660239 |
| 39 | Abnormality of the renal medulla (HP:0100957) | 2.19227890 |
| 40 | Oligodactyly (hands) (HP:0001180) | 2.16107186 |
| 41 | Gaze-evoked nystagmus (HP:0000640) | 2.15159019 |
| 42 | Hyperaldosteronism (HP:0000859) | 2.13706853 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.11317905 |
| 44 | Alkalosis (HP:0001948) | 2.10181887 |
| 45 | Renal salt wasting (HP:0000127) | 2.09028125 |
| 46 | Concave nail (HP:0001598) | 2.08672468 |
| 47 | Hypochromic anemia (HP:0001931) | 2.08092235 |
| 48 | Nephronophthisis (HP:0000090) | 2.07570707 |
| 49 | Focal seizures (HP:0007359) | 2.05335341 |
| 50 | Limb dystonia (HP:0002451) | 2.02634467 |
| 51 | Abnormality of the fingertips (HP:0001211) | 1.99627238 |
| 52 | Decreased circulating renin level (HP:0003351) | 1.98548135 |
| 53 | Increased IgM level (HP:0003496) | 1.98077546 |
| 54 | Clumsiness (HP:0002312) | 1.96441245 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94712514 |
| 56 | Broad-based gait (HP:0002136) | 1.93896063 |
| 57 | Cystic liver disease (HP:0006706) | 1.92769573 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90736759 |
| 59 | Abnormality of B cell number (HP:0010975) | 1.90582761 |
| 60 | Recurrent fungal infections (HP:0002841) | 1.90420981 |
| 61 | Status epilepticus (HP:0002133) | 1.89873819 |
| 62 | Tetany (HP:0001281) | 1.89475969 |
| 63 | Abnormality of magnesium homeostasis (HP:0004921) | 1.89294811 |
| 64 | Chronic diarrhea (HP:0002028) | 1.89225407 |
| 65 | Impaired smooth pursuit (HP:0007772) | 1.88104828 |
| 66 | Chronic hepatic failure (HP:0100626) | 1.86689959 |
| 67 | Parakeratosis (HP:0001036) | 1.86534151 |
| 68 | Thyroiditis (HP:0100646) | 1.83787184 |
| 69 | Amelogenesis imperfecta (HP:0000705) | 1.82082657 |
| 70 | Stomach cancer (HP:0012126) | 1.81488903 |
| 71 | Retinal dysplasia (HP:0007973) | 1.80721513 |
| 72 | Hypoplasia of the pons (HP:0012110) | 1.79661853 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 1.78852433 |
| 74 | Optic neuritis (HP:0100653) | 1.78852433 |
| 75 | Pendular nystagmus (HP:0012043) | 1.78256078 |
| 76 | Pancreatic fibrosis (HP:0100732) | 1.78041798 |
| 77 | Large for gestational age (HP:0001520) | 1.77958022 |
| 78 | Inability to walk (HP:0002540) | 1.77950729 |
| 79 | Attenuation of retinal blood vessels (HP:0007843) | 1.76276337 |
| 80 | Protruding tongue (HP:0010808) | 1.75948382 |
| 81 | Increased IgE level (HP:0003212) | 1.75756315 |
| 82 | Visual hallucinations (HP:0002367) | 1.75590858 |
| 83 | Encephalitis (HP:0002383) | 1.75487499 |
| 84 | Abnormality of binocular vision (HP:0011514) | 1.75367869 |
| 85 | Diplopia (HP:0000651) | 1.75367869 |
| 86 | Abnormality of the pons (HP:0007361) | 1.74993277 |
| 87 | Neonatal hypoglycemia (HP:0001998) | 1.73809881 |
| 88 | Recurrent bronchitis (HP:0002837) | 1.73780820 |
| 89 | B lymphocytopenia (HP:0010976) | 1.72996966 |
| 90 | Agitation (HP:0000713) | 1.72824282 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 1.71364623 |
| 92 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.69226240 |
| 93 | Eosinophilia (HP:0001880) | 1.67089001 |
| 94 | Oligodontia (HP:0000677) | 1.66919328 |
| 95 | Severe visual impairment (HP:0001141) | 1.66273341 |
| 96 | Vasculitis (HP:0002633) | 1.66078995 |
| 97 | Generalized hypopigmentation of hair (HP:0011358) | 1.65470206 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 1.65067615 |
| 99 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.64772262 |
| 100 | Hypokalemia (HP:0002900) | 1.64276100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.00692984 |
| 2 | TXK | 3.62542518 |
| 3 | CAMKK1 | 2.69915203 |
| 4 | WNK3 | 2.58251323 |
| 5 | SIK2 | 2.44225060 |
| 6 | CAMKK2 | 2.27783015 |
| 7 | FRK | 2.22518386 |
| 8 | OXSR1 | 2.18884482 |
| 9 | PASK | 2.09584752 |
| 10 | ITK | 2.07183329 |
| 11 | TNK2 | 2.04499904 |
| 12 | TYRO3 | 1.80496424 |
| 13 | WNK4 | 1.78855375 |
| 14 | NTRK2 | 1.66461077 |
| 15 | NLK | 1.60885696 |
| 16 | NTRK3 | 1.59607659 |
| 17 | CASK | 1.56609526 |
| 18 | DAPK2 | 1.51404154 |
| 19 | TAOK1 | 1.49171711 |
| 20 | ADRBK2 | 1.47505697 |
| 21 | MAP3K9 | 1.45232788 |
| 22 | FES | 1.37236798 |
| 23 | MAPK13 | 1.37110600 |
| 24 | IKBKE | 1.35346259 |
| 25 | CAMK1D | 1.34362202 |
| 26 | PRKCH | 1.32213505 |
| 27 | GRK6 | 1.29717632 |
| 28 | MAP3K11 | 1.27374165 |
| 29 | BTK | 1.26498471 |
| 30 | STK11 | 1.25614238 |
| 31 | MARK2 | 1.23958153 |
| 32 | SGK2 | 1.23419404 |
| 33 | TLK1 | 1.21562993 |
| 34 | SGK494 | 1.18760954 |
| 35 | SGK223 | 1.18760954 |
| 36 | MAP2K6 | 1.17257337 |
| 37 | LCK | 1.12080425 |
| 38 | BMPR1B | 1.11601118 |
| 39 | CDK19 | 1.05243165 |
| 40 | ZAP70 | 1.01921861 |
| 41 | PRKCQ | 1.01215559 |
| 42 | MARK3 | 0.98275963 |
| 43 | CAMK1 | 0.95435152 |
| 44 | FGFR2 | 0.95112645 |
| 45 | CAMK1G | 0.94989366 |
| 46 | IKBKB | 0.94195587 |
| 47 | RIPK4 | 0.94184587 |
| 48 | SYK | 0.91523061 |
| 49 | MAPK15 | 0.90319136 |
| 50 | PIK3CA | 0.88650713 |
| 51 | TAOK3 | 0.88461746 |
| 52 | TRIB3 | 0.85940473 |
| 53 | PRKCI | 0.85932375 |
| 54 | MARK1 | 0.83944635 |
| 55 | CHUK | 0.83827790 |
| 56 | PNCK | 0.82409603 |
| 57 | GRK1 | 0.81459303 |
| 58 | PRKD2 | 0.80345000 |
| 59 | MAP3K7 | 0.80082236 |
| 60 | STK39 | 0.78634549 |
| 61 | PRKD3 | 0.77964813 |
| 62 | PAK3 | 0.77817467 |
| 63 | MAP3K13 | 0.77199966 |
| 64 | FGFR4 | 0.76856575 |
| 65 | NEK6 | 0.75714722 |
| 66 | TEC | 0.75442787 |
| 67 | SIK3 | 0.75216539 |
| 68 | INSRR | 0.73905303 |
| 69 | IRAK4 | 0.73881320 |
| 70 | DYRK2 | 0.73806602 |
| 71 | PRKCG | 0.73217997 |
| 72 | UHMK1 | 0.72367453 |
| 73 | SGK3 | 0.71930817 |
| 74 | FGFR3 | 0.71917144 |
| 75 | HIPK2 | 0.71847823 |
| 76 | PDK1 | 0.70476806 |
| 77 | WNK1 | 0.69482500 |
| 78 | MAP3K4 | 0.68315653 |
| 79 | STK38 | 0.66949410 |
| 80 | PRKCZ | 0.66515004 |
| 81 | MAP2K2 | 0.63788465 |
| 82 | CSK | 0.63497772 |
| 83 | SIK1 | 0.61563517 |
| 84 | CAMK4 | 0.61251033 |
| 85 | JAK3 | 0.61168730 |
| 86 | HCK | 0.59825166 |
| 87 | SGK1 | 0.58233509 |
| 88 | DYRK1A | 0.55176890 |
| 89 | JAK1 | 0.54832189 |
| 90 | MINK1 | 0.51936460 |
| 91 | PINK1 | 0.50499392 |
| 92 | MAPK12 | 0.50341504 |
| 93 | MAPK11 | 0.44542347 |
| 94 | CDK5 | 0.44220902 |
| 95 | IRAK1 | 0.43511282 |
| 96 | LYN | 0.42784197 |
| 97 | PIM1 | 0.40301183 |
| 98 | MAP2K7 | 0.40139491 |
| 99 | MAPK8 | 0.38803834 |
| 100 | RPS6KA6 | 0.37847921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.78498494 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.02849077 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.76043074 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.37212345 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.34415459 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.27208451 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06027400 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 1.90217315 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89134181 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74471566 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.68752512 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64314984 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.55934004 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52388935 |
| 15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.51090606 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50093795 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.45289810 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42762470 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.39132698 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.37909314 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.35143602 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34409963 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.30734442 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28978386 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.28952993 |
| 26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.27502928 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.26299172 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.25039190 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24879384 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.24112030 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23945554 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22264548 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20805675 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.19500149 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17881146 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15758001 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15736885 |
| 38 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.14764916 |
| 39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.12684806 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12001167 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.10955854 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07900600 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04957742 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04365710 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04062465 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99649261 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98593895 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95754510 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93595336 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93248226 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92212182 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.91641157 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87636316 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86716800 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86132118 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84509444 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83596013 |
| 58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83115211 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82372945 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82192449 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79381311 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79025241 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78381591 |
| 64 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77263596 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.76914518 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.76671393 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71240338 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68338524 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66204608 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65278858 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62168380 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61174695 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61153571 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59746169 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58228497 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57271215 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56523990 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56285480 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54757867 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53327486 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.53134549 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52028098 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51222173 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51174169 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50647555 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50263661 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49428799 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49385606 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48868805 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.48149591 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46250416 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46226643 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45547651 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43792871 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.42578654 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42037596 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41244357 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40375013 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39917188 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39777582 |

